{"transactions":[{"id":3312430,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":152418,"kind":"organization","name":"Opaleye, L.P.","position":1,"cik":"0001391634","reported_name":"Opaleye, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-13T23:48:29.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":1426234,"price":7.01,"value":9997900.34,"ownership":{"direct":true},"balance_after":2208472,"source":{"system":"sec-edgar","filing":"0001209191-20-003219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120003219/doc4.xml","form_type":"4"}},{"id":3312429,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":152418,"kind":"organization","name":"Opaleye, L.P.","position":1,"cik":"0001391634","reported_name":"Opaleye, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-13T23:48:29.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":777635,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On September 23, 2019, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the \"Merger Agreement\") as amended on November 19, 2019, with the Issuer, REM 1 Acquisition, Inc. (\"Merger Sub\") and ArTara Subsidiary, Inc. (\"ArTara Sub\"). On January 9, 2020 (the \"Effective Time\"), Merger Sub was merged with and into ArTara Sub, with ArTara Sub surviving as a wholly-owned subsidiary of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were received in exchange for: i) 571,428 shares of ArTara Sub common stock; and ii) 3,505,174 shares of ArTara Sub exchangeable common stock, in connection with the merger."}],"balance_after":782238,"source":{"system":"sec-edgar","filing":"0001209191-20-003219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1359931/000120919120003219/doc4.xml","form_type":"4"}}]}